Literature DB >> 26592951

Differential cognitive actions of norepinephrine a2 and a1 receptor signaling in the prefrontal cortex.

Craig W Berridge1, Robert C Spencer2.   

Abstract

The prefrontal cortex (PFC) supports cognitive and behavioral processes that guide goal directed behavior. Moreover, dysregulated prefrontal cognitive dysfunction is associated with multiple psychiatric disorders. Norepinephrine (NE) signaling in the PFC is a critical modulator of prefrontal cognition and is targeted by a variety of drugs used to treat PFC-dependent cognitive dysfunction. Noradrenergic modulation of PFC-dependent cognition is complex, with concentration and receptor-specific actions that are likely dependent on neuronal activity state. Recent studies indicate that within the PFC, noradrenergic α1 and α2 receptors exert unique modulatory actions across distinct cognitive processes that allow for context-dependent modulation of cognition. Specifically, high affinity post-synaptic α2 receptors, engaged at moderate rates of NE release associated with moderate arousal levels, promote working memory. In contrast, lower affinity α1 receptors, engaged at higher rates of release associated with high arousal conditions (e.g. stress), impair working memory performance while promoting flexible attention. While these and other observations were initially interpreted to indicate high rates of NE release promotes the transition from focused to flexible/scanning attention, recent findings indicate that α1 receptors promote both focused and flexible attention. Collectively, these observations indicate that while α2 and α1 receptors in the PFC differentially modulate distinct cognitive processes, this cannot be simply ascribed to differential roles of these receptors in 'focused' vs. 'flexible' cognitive processes. Translationally, this information indicates that: (1) not all tests of prefrontal cognitive function may be appropriate for preclinical programs aimed at specific PFC-dependent disorders and (2) the treatment of specific PFC cognitive deficits may require the differential targeting of noradrenergic receptor subtypes. This article is part of a Special Issue entitled SI: Noradrenergic System.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Flexible Cognition; Norepinephrine; Prefrontal cortex; Sustained attention; Working memory

Mesh:

Substances:

Year:  2015        PMID: 26592951      PMCID: PMC4876052          DOI: 10.1016/j.brainres.2015.11.024

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  69 in total

1.  Selective deficit in no-go performance induced by blockade of prefrontal cortical alpha 2-adrenoceptors in monkeys.

Authors:  Chao-Lin Ma; Xue-Lian Qi; Ji-Yun Peng; Bao-Ming Li
Journal:  Neuroreport       Date:  2003-05-23       Impact factor: 1.837

Review 2.  Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions.

Authors:  Amy F T Arnsten; Bao-Ming Li
Journal:  Biol Psychiatry       Date:  2005-06-01       Impact factor: 13.382

Review 3.  Cellular basis of working memory.

Authors:  P S Goldman-Rakic
Journal:  Neuron       Date:  1995-03       Impact factor: 17.173

4.  Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability.

Authors:  M D S Lapiz; D A Morilak
Journal:  Neuroscience       Date:  2005-11-17       Impact factor: 3.590

Review 5.  Networks related to the orbital and medial prefrontal cortex; a substrate for emotional behavior?

Authors:  J L Price; S T Carmichael; W C Drevets
Journal:  Prog Brain Res       Date:  1996       Impact factor: 2.453

6.  Psychostimulants act within the prefrontal cortex to improve cognitive function.

Authors:  Robert C Spencer; Raymond M Klein; Craig W Berridge
Journal:  Biol Psychiatry       Date:  2011-12-29       Impact factor: 13.382

7.  A role for norepinephrine in stress-induced cognitive deficits: alpha-1-adrenoceptor mediation in the prefrontal cortex.

Authors:  S Birnbaum; K T Gobeske; J Auerbach; J R Taylor; A F Arnsten
Journal:  Biol Psychiatry       Date:  1999-11-01       Impact factor: 13.382

8.  Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine.

Authors:  R Kuczenski; D S Segal
Journal:  J Pharmacol Exp Ther       Date:  2001-03       Impact factor: 4.030

9.  Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men.

Authors:  J L Rapoport; M S Buchsbaum; H Weingartner; T P Zahn; C Ludlow; E J Mikkelsen
Journal:  Arch Gen Psychiatry       Date:  1980-08

10.  Dopamine, cognitive function, and gamma oscillations: role of D4 receptors.

Authors:  Katrina E Furth; Surjeet Mastwal; Kuan H Wang; Andres Buonanno; Detlef Vullhorst
Journal:  Front Cell Neurosci       Date:  2013-07-02       Impact factor: 5.505

View more
  29 in total

Review 1.  Glutamatergic regulation of cognition and functional brain connectivity: insights from pharmacological, genetic and translational schizophrenia research.

Authors:  Maria R Dauvermann; Graham Lee; Neil Dawson
Journal:  Br J Pharmacol       Date:  2017-08-11       Impact factor: 8.739

2.  A Genetically Encoded Fluorescent Sensor for Rapid and Specific In Vivo Detection of Norepinephrine.

Authors:  Jiesi Feng; Changmei Zhang; Julieta E Lischinsky; Miao Jing; Jingheng Zhou; Huan Wang; Yajun Zhang; Ao Dong; Zhaofa Wu; Hao Wu; Weiyu Chen; Peng Zhang; Jing Zou; S Andrew Hires; J Julius Zhu; Guohong Cui; Dayu Lin; Jiulin Du; Yulong Li
Journal:  Neuron       Date:  2019-03-25       Impact factor: 17.173

3.  Bidirectional pharmacological perturbations of the noradrenergic system differentially affect tactile detection.

Authors:  Jim McBurney-Lin; Yina Sun; Lucas S Tortorelli; Quynh Anh T Nguyen; Sachiko Haga-Yamanaka; Hongdian Yang
Journal:  Neuropharmacology       Date:  2020-05-21       Impact factor: 5.250

4.  A preliminary investigation into the effects of doxazosin on cognitive functioning in tobacco-deprived and -satiated smokers.

Authors:  Walter Roberts; Terril L Verplaetse; Kelly E Moore; Lindsay M Oberleitner; Sherry A McKee
Journal:  Hum Psychopharmacol       Date:  2018-05       Impact factor: 1.672

5.  Effects of clonidine on MMN and P3a amplitude in schizophrenia patients on stable medication.

Authors:  Caitlyn Kruiper; Birte Y Glenthøj; Bob Oranje
Journal:  Neuropsychopharmacology       Date:  2019-02-23       Impact factor: 7.853

Review 6.  Corticotropin-Releasing Factor (CRF) circuit modulation of cognition and motivation.

Authors:  Sofiya Hupalo; Courtney A Bryce; Debra A Bangasser; Craig W Berridge; Rita J Valentino; Stan B Floresco
Journal:  Neurosci Biobehav Rev       Date:  2019-06-15       Impact factor: 8.989

Review 7.  Impact of juvenile chronic stress on adult cortico-accumbal function: Implications for cognition and addiction.

Authors:  Michael J Watt; Matthew A Weber; Shaydel R Davies; Gina L Forster
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-06-19       Impact factor: 5.067

Review 8.  Locus coeruleus: a new look at the blue spot.

Authors:  Gina R Poe; Stephen Foote; Oxana Eschenko; Joshua P Johansen; Sebastien Bouret; Gary Aston-Jones; Carolyn W Harley; Denise Manahan-Vaughan; David Weinshenker; Rita Valentino; Craig Berridge; Daniel J Chandler; Barry Waterhouse; Susan J Sara
Journal:  Nat Rev Neurosci       Date:  2020-09-17       Impact factor: 34.870

9.  Distribution of the Noradrenaline Innervation and Adrenoceptors in the Macaque Monkey Thalamus.

Authors:  Isabel Pérez-Santos; Nicola Palomero-Gallagher; Karl Zilles; Carmen Cavada
Journal:  Cereb Cortex       Date:  2021-07-29       Impact factor: 5.357

10.  A locus coeruleus to dentate gyrus noradrenergic circuit modulates aversive contextual processing.

Authors:  Dong-Oh Seo; Eric T Zhang; Sean C Piantadosi; David J Marcus; Laura E Motard; Bryce K Kan; Adrian M Gomez; Tammy K Nguyen; Li Xia; Michael R Bruchas
Journal:  Neuron       Date:  2021-06-02       Impact factor: 18.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.